Nutrition · Nov 16, 2026

Nutritional and lifestyle strategies in obesity management during incretin-based therapy: a narrative review with practical recommendations

By Carlin Cambi MP, Monaco-Ferreira DV

The growing use of glucagon-like peptide 1 receptor agonists and dual glucagon-like peptide 1/gastric inhibitory polypeptide receptor agonists in obesity management has highlighted the need for structured nutritional care alongside pharmacotherapy. This narrative review describes the main nutritional pillars in the care of patients receiving incretin-based therapies and proposes a practical framework for nutritional follow-up. PubMed, Embase, and the Cochrane Library were searched from inception to May 2026. We independently selected studies on dietary intake, body composition, lean mass, sarcopenia, micronutrient inadequacies, gastrointestinal symptoms, and nutritional strategies and graded the evidence using the Oxford Centre for Evidence-Based Medicine 2011 levels. Specialized nutritional therapy, ideally delivered by a registered dietitian/nutritionist within a multidisciplinary team, is central to preserving muscle mass, preventing nutritional inadequacies, improving gastrointestinal tolerability, and sustaining weight loss. Adequate protein intake (1.2–1.6 g/kg/d), body composition monitoring, resistance exercise, hydration, and micronutrient surveillance are particularly relevant. We propose the preservation of muscle mass, routine screening for deficiencies, adequate hydration, tailored nutritional therapy, and observation of gastrointestinal symptoms framework; the Incretin Plate Model; and the Metabolic Hourglass Model. These expert-derived tools have not yet been validated. Individualized, systematized nutritional care may maximize the benefits of incretin-based therapies while reducing nutritional and functional risks. Prospective studies are needed to validate the proposed models and to establish standardized monitoring and supplementation protocols.

doi.org/10.1016/j.nut.2026.113452Open accessPubMed 43038853Interventions

AgingResearch.News